Skip to main content
. 2013 Jul 9;109(2):370–378. doi: 10.1038/bjc.2013.319

Figure 2.

Figure 2

IHC staining for HSP60 and HSP27 in pretherapeutic biopsies of two oesophageal adenocarcinoma cases. (AC) a CTX responder (No.745, TRG 1) and (DF) a non-responder (No.772, TRG 3), are shown ( × 200): (A) haematoxylin/eosin; (B) very strong HSP60 expression; (C) no HSP27 expression; (D) haematoxylin/eosin; (E) weak HSP60 expression; and (F) strong HSP27 expression.